Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00034957 · ClinicalTrials.gov registry record · Phase 2

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

A Phase 2 study of Carcinoma, Non-Small Cell Lung and Lung Neoplasms, sponsored by Pfizer.

Completed
Registry status
Phase 2
Development phase
12
Study locations

NCT00034957 is a Phase 2 study of Carcinoma, Non-Small Cell Lung and Lung Neoplasms that has completed, run by Pfizer. The trial reports 12 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00034957, a Phase 2 study of Carcinoma, Non-Small Cell Lung and Lung Neoplasms, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
12
Study locations

Study Summary

The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)

Conditions Studied

Carcinoma, Non-Small Cell Lung Lung Neoplasms

Interventions

  • DRUG Investigational drug

Study Locations (12)

California

  • Research Center - Berkeley
  • Research Center - Greenbrae
  • Research Center - Los Angeles
  • Research Center - Rancho Mirage

Texas

  • Research Center - Arlington
  • Research Center - Dallas

Illinois

  • Research Center - Chicago

Kentucky

  • Research Center - Louisville

Massachusetts

  • Research Center - West Boylston

Michigan

  • Research Center - Ann Arbor

New Hampshire

  • Research Center - Lebanon

Tennessee

  • Research Center - Nashville

Trial Details

FieldValue
Est. Completion 2002-10
Phase Phase 2

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00034957

The ClinicalTrials.gov registry entry for NCT00034957 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Carcinoma, Non-Small Cell Lung appearing as the primary indexed condition, and to 1 intervention - of which Investigational drug is the first listed.

NCT00034957 reports 12 study locations spanning 8 distinct geographic areas - top geographies include California, Texas, Illinois.

Frequently Asked Questions

What is clinical trial NCT00034957 about?

NCT00034957 is a clinical study titled "Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)". The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)

What is the current status of trial NCT00034957?

This trial is currently completed. It is a Phase 2 study. Estimated completion is 2002-10.

What conditions does trial NCT00034957 study?

This clinical trial studies the following conditions: Carcinoma, Non-Small Cell Lung, Lung Neoplasms.

What interventions are being tested in trial NCT00034957?

The interventions under investigation include: Investigational drug (DRUG).

Who is sponsoring clinical trial NCT00034957?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00034957 being conducted?

This trial has 12 study locations across California, Illinois, Kentucky, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoma, Non-Small Cell Lung

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Carcinoma, Non-Small Cell Lung

All registered trials for this condition

Lung Neoplasms

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.